Understanding the effects of stopping malaria prevention in young children in Mali
"Investigating the rebound effects of seasonal malaria chemoprevention (SMC) in Mali"
This study looks at how stopping a special malaria prevention treatment for young children in Mali affects the number of malaria cases, helping us understand what works best to keep kids healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Sciences, Tech & Tech of Bamako NIH-funded |
| Lab location | 1 site (Bamako, Mali) |
| Project ID | NIH-10898673 on NIH RePORTER |
What this research studies
This research investigates the impact of seasonal malaria chemoprevention (SMC) on children under five years old in Mali. It focuses on how stopping SMC due to age restrictions affects malaria rates in both compliant and non-compliant children. By enrolling a large cohort, the study aims to compare malaria occurrences between those who received the full treatment and those who did not. The findings could help improve malaria prevention strategies in the region.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under five years old who have participated in the seasonal malaria chemoprevention program.
Not a fit: Children over five years old or those who have not participated in the SMC program may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better malaria prevention strategies that protect children from severe malaria infections.
How similar studies have performed: Previous studies have shown significant decreases in malaria cases with SMC, but this research aims to explore the less understood rebound effects, making it a novel investigation.
Where this research is happening
Bamako, Mali
- Univ of Sciences, Tech & Tech of Bamako — Bamako, Mali (Active)
Researchers
- Principal investigator: Toure, Mahamoudou — Univ of Sciences, Tech & Tech of Bamako
- Study coordinator: Toure, Mahamoudou
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.